LifeMD Q4 2025 Revenue Falls 28.7% Yet Targets 2026 Revenue Above $250M
LifeMD reports a 28.7% dip in Q4 2025 revenue to $45.8M but projects a $250M+ annualized run‑rate for Q4 2026, driven by GLP‑1 demand and new partnerships.
2 minutes to read
LifeMD Inc
LifeMD Partners with NovoCare to Expand Wegovy Access, Forecasts Strong Earnings Growth
LifeMD Inc. has partnered with NovoCare to expand access to Wegovy, a popular weight loss medication, driving strong earnings growth and market confidence in the company’s future prospects.
3 minutes to read
LifeMD Inc. Soars as Telehealth Titan with Strategic Partnerships and Women’s Health Expansion
LifeMD Inc, a New York-based telehealth technology company, is making headlines with strategic partnerships and acquisitions that promise to redefine the landscape of virtual care and position it as a leader in the telehealth industry.
3 minutes to read